Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases

C. Felice; A. Lewis; Alessandro Armuzzi; J. O. Lindsay; A. Silver

doi:10.1111/apt.13008

Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases

C. Felice
, A. Lewis
, Alessandro Armuzzi
, J. O. Lindsay
, A. Silver

Università Cattolica del Sacro Cuore

Queen Mary University of London

Risultato della ricerca: Contributo in rivista › Articolo

69 Citazioni (Scopus)

Abstract

A link between histone deacetylases (HDACs) and intestinal inflammation has been established. HDAC inhibitors that target gut-selective inflammatory pathways represent a potential new therapeutic strategy in patients with refractory inflammatory bowel diseases (IBD).

Lingua originale	Inglese
pagine (da-a)	26-38
Numero di pagine	13
Rivista	ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume	41
DOI	https://doi.org/10.1111/apt.13008
Stato di pubblicazione	Pubblicato - 2014

Keywords

inflammatory bowel disease
therapeutic targets

Accesso al documento

10.1111/apt.13008

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{0b1c74dd64c64f79bd75186b1b344051,

title = "Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases",

abstract = "A link between histone deacetylases (HDACs) and intestinal inflammation has been established. HDAC inhibitors that target gut-selective inflammatory pathways represent a potential new therapeutic strategy in patients with refractory inflammatory bowel diseases (IBD).",

keywords = "inflammatory bowel disease, therapeutic targets, inflammatory bowel disease, therapeutic targets",

author = "C. Felice and A. Lewis and Alessandro Armuzzi and Lindsay, \{J. O.\} and A. Silver",

year = "2014",

doi = "10.1111/apt.13008",

language = "English",

volume = "41",

pages = "26--38",

journal = "ALIMENTARY PHARMACOLOGY \& THERAPEUTICS",

issn = "0269-2813",

publisher = "Blackwell Science Limited:PO Box 88, Oxford OX2 0NE United Kingdom:011 44 1865 776868, 011 44 1865 206038, EMAIL: [email protected], INTERNET: http://www.blackwell-science.com, Fax: 011 44 1865 721205",

}

TY - JOUR

T1 - Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases

AU - Felice, C.

AU - Lewis, A.

AU - Armuzzi, Alessandro

AU - Lindsay, J. O.

AU - Silver, A.

PY - 2014

Y1 - 2014

N2 - A link between histone deacetylases (HDACs) and intestinal inflammation has been established. HDAC inhibitors that target gut-selective inflammatory pathways represent a potential new therapeutic strategy in patients with refractory inflammatory bowel diseases (IBD).

AB - A link between histone deacetylases (HDACs) and intestinal inflammation has been established. HDAC inhibitors that target gut-selective inflammatory pathways represent a potential new therapeutic strategy in patients with refractory inflammatory bowel diseases (IBD).

KW - inflammatory bowel disease

KW - therapeutic targets

KW - inflammatory bowel disease

KW - therapeutic targets

UR - http://hdl.handle.net/10807/64558

U2 - 10.1111/apt.13008

DO - 10.1111/apt.13008

M3 - Article

SN - 0269-2813

VL - 41

SP - 26

EP - 38

JO - ALIMENTARY PHARMACOLOGY & THERAPEUTICS

JF - ALIMENTARY PHARMACOLOGY & THERAPEUTICS

ER -

Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo